Literature DB >> 26348459

Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.

Venkatesan Chakrapani1,2, Peter A Newman3, Murali Shunmugam1, Shruta Mengle2, Jarvis Varghese2, Ruban Nelson1, Shalini Bharat4.   

Abstract

This qualitative study explored the acceptability of HIV pre-exposure prophylaxis (PrEP) among MSM in India, and identified facilitators and barriers to future PrEP uptake. In 2014, we conducted 10 focus groups (n=61) among a purposive sample of diverse MSM recruited through community-based organizations in Chennai and Mumbai, and 10 key informant interviews with community leaders and health care providers. Participants' mean age was 26.1 years (SD 4.8); 62% completed secondary education, and 42% engaged in sex work. No focus group participants had heard of PrEP, but once explained, most reported they would likely use it. PrEP was alternately perceived as a 'back-up plan', a condom substitute, or a burden with concurrent condom use. Facilitators were potential for covert use, sex without condoms, and anxiety-less sex. Potential barriers emerged around stigma associated with PrEP use, fear of disclosures to one's family, wife, or male steady partner, and being labeled as HIV-positive or promiscuous by peers. Preferences emerged for intermittent rather than daily PrEP use, injectable PrEP, and free or subsidized access through community organizations or government hospitals. Key informants expressed additional concerns about risk compensation, non-adherence, and impact on ART availability for treatment. Demonstration projects are needed in India to support PrEP implementation tailored for at-risk MSM. Educational interventions for MSM should address concerns about PrEP effectiveness, side effects, and mitigate risk compensation. Community engagement may facilitate broad acceptability and challenge stigma around PrEP use. Importantly, provision of free or subsidized PrEP is necessary to making implementation feasible among low socioeconomic status MSM in India.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26348459     DOI: 10.1089/apc.2015.0143

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  33 in total

Review 1.  Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.

Authors:  Kellie Freeborn; Carmen J Portillo
Journal:  J Clin Nurs       Date:  2018-09       Impact factor: 3.036

2.  A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease.

Authors:  Pooyan Kazemian; Sydney Costantini; Anne M Neilan; Stephen C Resch; Rochelle P Walensky; Milton C Weinstein; Kenneth A Freedberg
Journal:  J Biomed Inform       Date:  2020-06-08       Impact factor: 6.317

3.  HIV stigma is a barrier to achieving 90-90-90 in India.

Authors:  Maria L Ekstrand; Shalini Bharat; Krishnamachari Srinivasan
Journal:  Lancet HIV       Date:  2018-10-08       Impact factor: 12.767

4.  Risk Behavior Not Associated with Self-Perception of PrEP Candidacy: Implications for Designing PrEP Services.

Authors:  Lu Xie; Yumeng Wu; Siyan Meng; Jianhua Hou; Rong Fu; Huang Zheng; Na He; Min Wang; Kathrine Meyers
Journal:  AIDS Behav       Date:  2019-10

5.  Temporal Fluctuations in Behavior, Perceived HIV Risk, and Willingness to Use Pre-Exposure Prophylaxis (PrEP).

Authors:  Kristen Underhill; Kate M Guthrie; Christopher Colleran; Sarah K Calabrese; Don Operario; Kenneth H Mayer
Journal:  Arch Sex Behav       Date:  2018-01-11

6.  Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project.

Authors:  Susanne Doblecki-Lewis; Albert Liu; Daniel Feaster; Stephanie E Cohen; Gabriel Cardenas; Oliver Bacon; Erin Andrew; Michael A Kolber
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

7.  Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment.

Authors:  Venkatesan Chakrapani; Peter A Newman; Michael Cameron; Murali Shunmugam; Surachet Roungprakhon; Shruta Rawat; Dicky Baruah; Ruban Nelson; Suchon Tepjan; Riccardo Scarpa
Journal:  AIDS Behav       Date:  2021-04-05

8.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12

9.  PrEP eligibility, HIV risk perception, and willingness to use PrEP among high-risk men who have sex with men in India: A cross-sectional survey.

Authors:  Venkatesan Chakrapani; Peter A Newman; Murali Shunmugam; Shruta Rawat; Dicky Baruah; Ruban Nelson; Surachet Roungkraphon; Suchon Tepjan
Journal:  AIDS Care       Date:  2021-02-21

10.  Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.

Authors:  Venkatesan Chakrapani; Murali Shunmugam; Shruta Rawat; Dicky Baruah; Ruban Nelson; Peter A Newman
Journal:  AIDS Patient Care STDS       Date:  2020-01-17       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.